Awareness : Did You Know? 2015-2016

Did You Know? Weekly Educational Series 34

For the Week of May 23, 2016

Coverage of Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) for treatment of multiple myeloma, myelofibrosis, and sickle cell disease is covered by Medicare, but only if provided in the context of a Medicare-approved clinical study meeting specific criteria. There is also ICD-10 diagnosis codes for allogeneic HSCT for treatment of myelodysplastic syndromes clarification.

Additional information is available in the MLN MattersĀ® article MM9620